We are excited to introduce Dr. Rachna Shroff, a prominent figure in oncology and a leader in gastrointestinal cancers, as our next oncoinfluencer.
Dr. Shroff is highly active on X/Twitter and LinkedIn, where she shares her extensive expertise in clinical investigations and research, particularly focusing on pancreatic and hepatobiliary cancers. Her posts provide invaluable insights into the latest advancements in novel therapies and clinical research strategies.
Follow Dr. Rachna Shroff on X/Twitter and LinkedIn to stay updated on her groundbreaking work and contributions to advancing oncology research and clinical practice.
About Dr. Rachna Shroff
Dr. Rachna Shroff is an Associate Director of Clinical Investigations at the University of Arizona Cancer Center (UACC) and co-leader of the Gastrointestinal Clinical Research Team. She also serves as the Associate Dean for Clinical and Translational Research for the University of Arizona College of Medicine – Tucson.
Dr. Shroff is the Hepatobiliary Subcommittee co-chair for the Southwest Oncology Group (SWOG) and will chair GI ASCO 2024. She is also a member of the ASCO Nominating Committee. Her research focuses on the development of novel therapies for pancreatic and hepatobiliary cancers.
Dr. Shroff’s work continues to drive innovation in cancer treatment and improve outcomes for patients with gastrointestinal malignancies.
Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.